Abdominal Adiposity and Diabetes Risk
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Obesity is perhaps the longest studied and best described risk factor for type 2 diabetes. Epidemiologic investigations have consistently shown an independent increased risk for diabetes associated with overweight and obesity, with clear dose response patterning across categories of increasing body mass. While the importance of increased body mass in diabetes etiology is unequivocal, it has been recognized for some time that the distribution of body fat provides additional resolution regarding diabetes risk. In 1947, Vague (1) noted that an android (male or upper body) pattern of obesity was associated with a poorer metabolic profile compared with a gynecoid (lower body) pattern. These clinical observations regarding the detrimental health effects of central or upper body obesity were subsequently reinforced by the results of large prospective epidemiological studies of diabetes incidence, in which fat patterning of subjects was estimated using body surface measurements, specifically waist and hip circumferences and skinfold thicknesses (2–5). While these and other studies have reported superior prediction of diabetes with waist circumference or waist-to-hip ratio compared with BMI, it is notable that this is far from a universal finding. Indeed, a recent meta-analysis of 32 studies concluded that BMI, waist circumference, and waist-to-hip ratio had similar associations with incident diabetes (6). This lack of clarity in the epidemiologic literature regarding optimal measures of obesity for studies of diabetes risk is due at least in part to the nature of these proxy (surrogate) measurements. Body surface measures such as waist circumference do not distinguish between the various adipose tissue depots, which are known to have differences in biologic function. Specifically, there can be sizable differences in the amounts of visceral (VAT) and subcutaneous adipose tissue (SAT) …
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These changes are associated with insulin resistance, as opposed to insulin-sensitive obesity, which is associated with proportionally more healthy subcutaneous fat cells and less visceral fat (8,13,14).”
From Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU) (2011) · cites this paper as [13]
Citations
Cites
Fox, C. S., Massaro, J. M., Hoffmann, U., Pou, K. M., Maurovich-Horvat, P., Liu, C.-Y., Vasan, R. S., Murabito, J. M., Meigs, J. B., Cupples, L. A., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.675355 · Cited by 2,882
Vazquez, G., Duval, S., Jacobs, D. R., & Silventoinen, K. (2007) · Epidemiologic Reviews · doi:10.1093/epirev/mxm008 · Cited by 976 · cited 1×
“Indeed, a recent meta-analysis of 32 studies concluded that BMI, waist circumference, and waist-to-hip ratio had similar associations with incident diabetes (6).”
ResultCarey, V. J., Walters, E. E., Colditz, G. A., Solomon, C. G., Willet, W. C., Rosner, B. A., Speizer, F. E., & Manson, J. E. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009158 · Cited by 827
Folsom, A. R., Kushi, L. H., Anderson, K. E., Mink, P. J., Olson, J. E., Hong, C.-P., Sellers, T. A., Lazovich, D., & Prineas, R. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2117 · Cited by 684
Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans.
Boyko, E. J., Fujimoto, W. Y., Leonetti, D. L., & Newell-Morris, L. (2000) · Diabetes Care · doi:10.2337/diacare.23.4.465 · Cited by 579
Hanson, R. L., Pratley, R. E., Bogardus, C., Narayan, K. M. V., Roumain, J. M. L., Imperatore, G., Fagot-Campagna, A., Pettitt, D. J., Bennett, P. H., & Knowler, W. C. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010187 · Cited by 463 · cited 1×
“Notwithstanding, the latter procedures are expensive and invasive, and proxy indexes of insulin resistance that use information from oral glucose tolerance tests show acceptable validity for epidemiological applications (16,17).”
BackgroundStudy, F. T. H. A., Snijder, M. B., Visser, M., Dekker, J. M., Goodpaster, B. H., Harris, T. B., Kritchevsky, S. B., De Rekeneire, N., Kanaya, A. M., Newman, A. B., et al. (2005) · Diabetologia · doi:10.1007/s00125-004-1637-7 · Cited by 412
Insulin Sensitivity, Insulin Secretion, and Abdominal Fat
Wagenknecht, L. E., Langefeld, C. D., Scherzinger, A. L., Norris, J. M., Haffner, S. M., Saad, M. F., & Bergman, R. N. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2490 · Cited by 303
Self-citationVisceral Fat and Race-Dependent Health Risks in Obese Nondiabetic Premenopausal Women
Albu, J. B., Murphy, L., Frager, D. H., Johnson, J. A., & Pi-Sunyer, F. X. (1997) · Diabetes · doi:10.2337/diab.46.3.456 · Cited by 259
Hill, J. O., Sidney, S., Lewis, C. E., Tolan, K., Scherzinger, A. L., & Stamm, E. R. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.3.381 · Cited by 257
Cited by
Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU)
Rowan, J. A., Rush, E. C., Obolonkin, V., Battin, M., Wouldes, T., & Hague, W. M. (2011) · Diabetes Care · doi:10.2337/dc11-0660 · Cited by 379
Hanley, A. J. G., Wagenknecht, L. E., Norris, J. M., Bryer-Ash, M., Chen, Y. I., Anderson, A. M., Bergman, R., & Haffner, S. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1464-y · Cited by 115
Self-citationLim, S., Yoon, J. W., Choi, S. H., Park, Y. J., Lee, J. J., Park, J. H., Lee, S. B., Kim, K. W., Lim, J., Kim, Y., et al. (2010) · Obesity · doi:10.1038/oby.2009.232 · Cited by 51
Low Plasma Adiponectin Concentrations Predict Increases in Visceral Adiposity and Insulin Resistance
Han, S. J., Boyko, E. J., Fujimoto, W. Y., Kahn, S. E., & Leonetti, D. L. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01703 · Cited by 50
Serum butyrylcholinesterase and the risk of future type 2 diabetes: the Kansai Healthcare Study
Satō, K., Hayashi, T., Maeda, I., Koh, H., Harita, N., Uehara, S., Onishi, Y., Oue, K., Nakamura, Y., Endo, G., et al. (2013) · Clinical Endocrinology · doi:10.1111/cen.12171 · Cited by 33
State legislators' support for evidence-based obesity reduction policies
Welch, P., Dake, J. A., Price, J. H., Thompson, A. J., & Ubokudom, S. E. (2012) · Preventive Medicine · doi:10.1016/j.ypmed.2012.09.008 · Cited by 22
Obesidade e fatores associados em adultos
Swarowsky, I., Reuter, É. M., Ferreira, C., Priebe, P., Paiva, D. N., & Pohl, H. H. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · doi:10.17058/cinergis.v13i1.2845 · Cited by 17
Longer-term outcomes in offspring of GDM mothers treated with metformin versus insulin
Zhen, X. M., Li, X., & Chen, C. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.07.002 · Cited by 17
Rush, E. C., Obolonkin, V., Battin, M., Wouldes, T., & Rowan, J. (2015) · Annals of Human Biology · doi:10.3109/03014460.2014.959999 · Cited by 13
Premanath, M., Basavanagowdappa, H., Mahesh, M., & Babu, M. (2017) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_418_16 · Cited by 7
Identification of Sortilin Alternatively Spliced Variants in Mouse 3T3L1 Adipocytes
Lui, A., Sparks, R. P., Patel, R. S., & Patel, N. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22030983 · Cited by 5
Mihai, A. D., Carniciu, S., Iancu, C., Petcu, L. M., Mitu, M., Picu, A. A., Tudosoiu, J., Stoian, I. A.-M., Lixandru, D., Ionescu-Tirgoviste, C., et al. (2014)
Metadata
- Authors
- Hanley, A. J. G., & Wagenknecht, L. E.
- Affiliations
- University of Toronto (CA)
- Wake Forest University Health Sciences (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-05-01
- Volume
- 57
- Issue
- 5
- Pages
- 1153-1155
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2411756593
- Cited by
- 12
- References
- 20
- Citations by year
- 2021: 1 · 2018: 1 · 2017: 2 · 2014: 2 · 2013: 1 · 2012: 2
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- abdominal fat, type 2 diabetes risk, obesity, visceral adipose tissue, subcutaneous adipose tissue, waist circumference, waist-to-hip ratio, body mass index, android obesity, gynoid obesity, adipose tissue depots, skinfold thickness
- MeSH terms
- Abdomen, Adipose Tissue, Diabetes Mellitus, Humans, Longitudinal Studies, Obesity, Risk Factors, Reproducibility of Results, Body Mass Index, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.